Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants
Authors:
- 29 March 2010
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 99 (5) , 673-678
Abstract
Objectives: To assess the influence of clinical status on the association between total plasma bilirubin and unbound bilirubin on death or adverse neurodevelopmental outcomes at 18–22 months corrected age in extremely low birth weight infants.Method: Total plasma bilirubin and unbound bilirubin were measured in 1101 extremely low birth weight infants at 5 ± 1 days of age. Clinical criteria were used to classify infants as clinically stable or unstable. Survivors were examined at 18–22 months corrected age by certified examiners. Outcome variables were death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss, and death prior to follow‐up. For all outcomes, the interaction between bilirubin variables and clinical status was assessed in logistic regression analyses adjusted for multiple risk factors.Results: Regardless of clinical status, an increasing level of unbound bilirubin was associated with higher rates of death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss and death before follow‐up. Total plasma bilirubin values were directly associated with death or neurodevelopmental impairment, death or cerebral palsy, death or hearing loss, and death before follow‐up in unstable infants, but not in stable infants. An inverse association between total plasma bilirubin and death or cerebral palsy was found in stable infants.Conclusions: In extremely low birth weight infants, clinical status at 5 days of age affects the association between total plasma bilirubin and death or adverse neurodevelopmental outcomes at 18–22 months of corrected age. An increasing level of UB is associated a higher risk of death or adverse neurodevelopmental outcomes regardless of clinical status. Increasing levels of total plasma bilirubin are directly associated with increasing risk of death or adverse neurodevelopmental outcomes in unstable, but not in stable infants.Keywords
This publication has 30 references indexed in Scilit:
- Aggressive vs. Conservative Phototherapy for Infants with Extremely Low Birth WeightNew England Journal of Medicine, 2008
- Bilirubin and ascorbate antioxidant activity in neonatal plasmaFEBS Letters, 1994
- The risk of bilirubin encephalopathy, as estimated by plasma parameters, in neonates strongly suspected of having sepsisActa Paediatrica, 1993
- The possible risk of bilirubin encephalopathy as predicted by plasma parameters in neonates with previous severe asphyxiaEuropean Journal of Pediatrics, 1992
- Reduced Albumin Binding of MADDS–a Measure for Bilirubin Binding–in Sick ChildrenActa Paediatrica, 1986
- Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infantsThe Journal of Pediatrics, 1980
- Displacement of bilirubin from human albumin bythree diureticsThe Journal of Pediatrics, 1977
- Competitive Binding of Bilirubin and Drugs to Human Serum Albumin Studied by Enzymatic OxidationJournal of Clinical Investigation, 1974
- Correlation of neonatal serum total bilirubinconcentrations and developmental status at age eight monthsThe Journal of Pediatrics, 1967
- STUDIES IN KERNICTERUS. I. THE PROTEIN BINDING OF BILIRUBIN*Journal of Clinical Investigation, 1959